We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$193M
AUM Growth
+$26.6M
Cap. Flow
+$12.8M
Cap. Flow %
6.67%
Top 10 Hldgs %
42%
Holding
497
New
58
Increased
61
Reduced
95
Closed
51

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.89M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$5.4M
3
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$2.27M
4
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$859K
5
SFM icon
Sprouts Farmers Market
SFM
+$393K

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$567K
2
CLX icon
Clorox
CLX
+$402K
3
TAP icon
Molson Coors Class B
TAP
+$368K
4
KMX icon
CarMax
KMX
+$275K
5
SYF icon
Synchrony
SYF
+$266K

Sector Composition

Rank Sector Weight
1 Technology 5.58%
2 Financials 2.75%
3 Communication Services 2.46%
4 Healthcare 2.26%
5 Industrials 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSYS icon
426
Stratasys
SSYS
$773M
$459 ﹤0.01%
40
– –
GT icon
427
Goodyear
GT
$1.78B
$456 ﹤0.01%
+44
New +$466
CTRI icon
428
Centuri Holdings
CTRI
$2.45B
$449 ﹤0.01%
+20
New +$391
CYH icon
429
Community Health Systems
CYH
$413M
$445 ﹤0.01%
+131
New +$421
TTEC icon
430
TTEC Holdings
TTEC
$83.2M
$443 ﹤0.01%
+92
New +$422
SFIX
431
Stitch Fix
SFIX
$503M
$414 ﹤0.01%
+112
New +$419
DHC
432
Diversified Healthcare Trust
DHC
$1.98B
$358 ﹤0.01%
+100
New +$289
PATH icon
433
UiPath
PATH
$8.01B
$358 ﹤0.01%
28
– –
MTLS
434
Materialise
MTLS
$393M
$299 ﹤0.01%
53
– –
CERS icon
435
Cerus
CERS
$530M
$271 ﹤0.01%
192
– –
BEAM icon
436
Beam Therapeutics
BEAM
$2.79B
$255 ﹤0.01%
15
– –
U icon
437
Unity
U
$19B
$242 ﹤0.01%
10
– –
TXG icon
438
10x Genomics
TXG
$7.77B
$139 ﹤0.01%
12
– –
TDOC icon
439
Teladoc Health
TDOC
$1.25B
$131 ﹤0.01%
15
– –
PACB icon
440
Pacific Biosciences
PACB
$357M
$119 ﹤0.01%
96
– –
NTLA icon
441
Intellia Therapeutics
NTLA
$1.68B
$113 ﹤0.01%
12
– –
ANGI icon
442
Angi Inc
ANGI
$185M
$107 ﹤0.01%
+7
New +$101
TSP
443
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$20 ﹤0.01%
66
– –
ABBV icon
444
AbbVie
ABBV
$438B
– –
-813
Closed -$170K
AFRM icon
445
Affirm
AFRM
$25.6B
– –
-3,312
Closed -$150K
AIQ icon
446
Global X Artificial Intelligence & Technology ETF
AIQ
$10.2B
– –
-763
Closed -$27.8K
ALRM icon
447
Alarm.com
ALRM
$2.76B
– –
-585
Closed -$32.6K
ANF icon
448
Abercrombie & Fitch
ANF
$5.27B
– –
-680
Closed -$51.9K
AROC icon
449
Archrock
AROC
$5.84B
– –
-28
Closed -$735
ASLE icon
450
AerSale
ASLE
$278M
– –
-507
Closed -$3.8K
16 17
18
19 20

Similar funds

TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
IH
IES Holdings Houston, Texas $214M AUM
SIA
Serenity Investment Advisors Chicago, Illinois $214M AUM
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
PFA
Pinnacle Family Advisors Springfield, Missouri $213M AUM 24.93% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
CHA
Cooper/Haims Advisors Victor, New York $212M AUM 12.19% 1-Year Est. Return

C.M. Bidwell & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, C.M. Bidwell & Associates held 497 positions worth $193M, up 16% from $166M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

C.M. Bidwell & Associates deployed $12.8M of net new capital in Q2 2025, opening 58 new positions and adding to 61 existing holdings. Its largest new stake was McDonald's: 909 shares worth $266K.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Applovin, an estimated $567K trimmed.

  • C.M. Bidwell & Associates's largest Q2 2025 buy was McDonald's: 909 shares worth $266K.
  • C.M. Bidwell & Associates added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $5.89M increase.
  • C.M. Bidwell & Associates's biggest Q2 2025 reduction was Applovin, cutting an estimated $567K.
  • C.M. Bidwell & Associates fully exited Molson Coors Class B in Q2 2025, selling an estimated $368K.
  • C.M. Bidwell & Associates's ten largest holdings make up 42% of its $193M portfolio in Q2 2025.
  • C.M. Bidwell & Associates opened 58 new positions and closed 51 in Q2 2025.
  • C.M. Bidwell & Associates's portfolio value rose 16% quarter-over-quarter to $193M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2025, filed 14 Aug 2025.